Ruben Mesa’s work on how to keep up the pace of timely drug development – Levine Cancer

Levine Cancer shared a post on X:

“Survivors are living longer thanks to new anticancer therapies, so the Overall Survival endpoint is a critical focus of oncology trials.

Dr. Ruben Mesa worked at Clinical Cancer Research and the American Association for Cancer Research on a paper detailing how to keep up the pace of timely drug development.